angiotensin ii has been researched along with ramiprilat in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 11 (64.71) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jahnecke, C; Kappes-Horn, K; Kramer, HJ; Meyer-Lehnert, H | 1 |
| Collier, JG; Webb, DJ | 1 |
| Abrahamsson, T; Carlsson, L | 1 |
| Kimura, BK; Phillips, MI | 1 |
| Hartman, JC | 1 |
| Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH | 1 |
| Brasch, H; Dominiak, P; Sieroslawski, L | 1 |
| Chatterjee, K; Ives, HE; Sudhir, K; Wilson, E | 1 |
| Hartman, JC; Hullinger, TG; Shebuski, RJ; Wall, TM | 1 |
| Cachofeiro, V; Guan, H; Kaminski, PM; Nasjletti, A; Pucci, ML; Wolin, MS | 1 |
| Bauer, JH; Campbell, F; Knaus, J; Reams, G; Weaver-Osterholtz, D; Wu, Z | 1 |
| Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lima, DX; Oliveira, RC; Santos, RA | 1 |
| Dunham, EW; Zhang, X; Zimmerman, BG | 1 |
| Bohlender, J; Dietz, R; Haass, M; Höhnel, K; Luft, FC; Scheuermann, M; Thibault, G; Willenbrock, R | 1 |
| Daniel, WG; Eskafi, S; Gabler, C; Garlichs, CD; Illmer, T; Lorenz, HM; Roerick, O; Schmeisser, A; Soehnlein, O; Strasser, R | 1 |
| Araghi, A; Beierwaltes, WH; Doci, TM; Mattingly, R; Yingst, DR | 1 |
| Angeli, F; Garofoli, M; Gentile, G; Martire, P; Mazzotta, G; Reboldi, G; Verdecchia, P | 1 |
1 review(s) available for angiotensin ii and ramiprilat
| Article | Year |
|---|---|
Aliskiren versus ramipril in hypertension.
Topics: Aging; Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetic Angiopathies; Fumarates; Half-Life; Humans; Hypertension; Ramipril; Renin-Angiotensin System | 2010 |
16 other study(ies) available for angiotensin ii and ramiprilat
| Article | Year |
|---|---|
[Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Bridged Bicyclo Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Culture Techniques; Dose-Response Relationship, Drug; Gallic Acid; Muscle, Smooth, Vascular; Pyrroles; Ramipril; Rats; Verapamil | 1991 |
Vascular angiotensin conversion in humans.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Forearm; Humans; Hypertension; Kinetics; Peptidyl-Dipeptidase A; Pyrroles; Ramipril; Reference Values; Regional Blood Flow; Renin | 1986 |
Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Creatine Kinase; Heart; In Vitro Techniques; Indomethacin; Male; Myocardium; Norepinephrine; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Saralasin | 1989 |
Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain; Hypertension; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spinal Cord | 1986 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diclofenac; Dogs; Electric Stimulation; Female; Norepinephrine; Perfusion; Prostaglandins; Ramipril; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 1994 |
Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Heart Atria; Imidazoles; In Vitro Techniques; Kinetics; Losartan; Male; Myocardium; Norepinephrine; Ramipril; Receptors, Angiotensin; Tetrazoles | 1993 |
Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biphenyl Compounds; Cell Division; Cells, Cultured; Collagen; DNA; Drug Synergism; Fibronectins; Gelatin; Imidazoles; Losartan; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Ramipril; Rats; Recombinant Proteins; Stress, Mechanical; Tetrazoles; Thymidine | 1993 |
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Electrophysiology; Female; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Rabbits; Ramipril; Tetrazoles | 1993 |
Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Arginine; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Vasoconstrictor Agents | 1996 |
The urinary bladder angiotensin system: response to infusions of angiotensin I and angiotensin-converting enzyme inhibitors.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Enalaprilat; Male; Ramipril; Rats; Rats, Sprague-Dawley; Urinary Bladder | 1996 |
Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1996 |
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation | 1995 |
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Heart Failure; Male; Myocardium; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Statistics, Nonparametric; Tetrazoles; Valine; Valsartan | 1999 |
ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Chemokine CCL2; Chemokines; Down-Regulation; Drug Interactions; Endothelium, Vascular; Humans; Imidazoles; Interleukin-8; Losartan; Monocytes; NF-kappa B; Peptidyl-Dipeptidase A; Pyridines; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Simvastatin; Umbilical Veins | 2004 |
Decreased renal perfusion rapidly increases plasma membrane Na-K-ATPase in rat cortex by an angiotensin II-dependent mechanism.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biotin; Blood Pressure; Cell Membrane; In Vitro Techniques; Kidney Cortex; Male; Microsomes; Ramipril; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; Renin; Sodium-Potassium-Exchanging ATPase | 2009 |